Kodiak Sciences Quarterly Balance Sheet
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kodiak Sciences financial position
As of Jun 30, 2026, Kodiak Sciences reported total assets of $256.8 million, up 0.0% from a year earlier against total liabilities of $195.7 million. Shareholders' equity stood at $61.1 million, or 23.8% of assets. The company held $125.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.49, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Kodiak Sciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 125.90M | 169.53M | 209.86M | 72.04M | 104.17M | 138.85M | 168.07M | 197.86M | 219.22M | 245.92M | 285.51M | 345.67M |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Total Current Assets | 131.36M | 175.26M | 214.82M | 75.73M | 107.92M | 142.69M | 171.94M | 202.49M | 224.63M | 251.51M | 289.31M | 350.93M |
| Property, Plant & Equipment | 78.31M | 81.51M | 85.26M | 88.91M | 93.43M | 97.90M | 102.22M | 106.69M | 111.33M | 115.80M | 120.48M | 125.19M |
| Total Assets | 256.81M | 306.01M | 351.53M | 218.07M | 256.73M | 297.91M | 335.58M | 372.67M | 401.58M | 434.76M | 479.37M | 547.65M |
| Accounts Payable | 12.64M | 11.34M | 12.86M | 10.37M | 5.06M | 6.54M | 3.92M | 3.29M | 1.87M | 2.48M | 13.61M | 38.59M |
| Total Current Liabilities | 52.77M | 49.57M | 45.53M | 42.43M | 31.01M | 30.88M | 25.57M | 24.06M | 21.20M | 24.86M | 41.73M | 70.77M |
| Total Liabilities | 195.72M | 193.91M | 194.15M | 194.38M | 186.44M | 189.07M | 185.29M | 187.30M | 187.07M | 193.57M | 213.59M | 245.24M |
| Shareholders' Equity | 61.10M | 112.10M | 157.38M | 23.69M | 70.29M | 108.84M | 150.29M | 185.37M | 214.51M | 241.19M | 265.78M | 302.42M |
| Retained Earnings | -1.68B | -1.62B | -1.56B | -1.50B | -1.44B | -1.39B | -1.33B | -1.28B | -1.24B | -1.20B | -1.15B | -1.09B |
| Net Cash (Debt) | 125.90M | 169.53M | 209.86M | 72.04M | 104.17M | 138.85M | 168.07M | 197.86M | 219.22M | 245.92M | 285.51M | 345.67M |
| Shares Outstanding | 62.83M | 62.16M | 61.76M | 53.00M | 52.82M | 52.75M | 52.73M | 52.62M | 52.61M | 52.52M | 52.51M | 52.47M |
This table shows 12 quarterly periods of Kodiak Sciences's balance sheet, from Q2 2026 back to Q3 2023, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow KOD's reporting calendar. What is a balance sheet?